25+ years of experience advancing therapies from research to development driving innovation in oncology, immuno-oncology and immunotherapy. Scaling organizations from start-up to biotech while advancing 10+ candidates to PoC. Expert in translating complex research into clinical reality, with deep experience navigating REG pathways in CH, EU and US and building high-performing teams.

20+ years of experience in biotech/pharma R&D, driving portfolio strategy, strategic alliances, governance, and data-driven decision-making from discovery through clinical development. Proven track record designing and scaling business and operating models translating science and constraints into executable plans, and investment cases.

25+ years of experience in immunology and immuno‑oncology, covering non‑clinical development, regulatory affairs, and clinical translation. Has led multiple cancer vaccine programs from discovery through early clinical development, combining deep biology with execution‑driven, regulator‑ready decision‑making. Demonstrated success in regulatory compliance and managing collaborations with various academic, CROs and pharmaceutical partners.

12+ years of experience in biologics, from research-stage protein production to sponsor-side CMC leadership in oncology and immunology. Deep expertise in CDMO oversight, CMC regulatory strategy, and delivery of IND- and IMPD-enabling packages with pharma-grade rigor at biotech speed.

17+ years of experience in Corporate administration, Executive Office management, Governance support, Information management and Stakeholder liaison. Proven experience managing the full biotech lifecycle, from early due diligence and company formation through growth, scale‑up, and exit.

10+ years of experience in the biotech field, successfully advancing two candidate vaccines from research to Phase I clinical development.

Experienced in driving complex early-stage cross-functional programs across international teams, with proven ability to operate in lean organizations. High level expertise in project management, process implementation and vendor management, combined with hands-on experience in biomarker analysis and supply chain management.

20+ years of experience in quality operations across the pharmaceutical and biotech industry. Expertise in GMP-regulated environments, quality systems, auditing, vendor oversight, and support to manufacturing and development activities. Strong track record ensuring compliant, efficient execution across development programs, from early development through Proof of Concept, in line with international GxP standards.

30+ years of experience in regulatory affairs across biotech and pharma, supporting development from early research to clinical and regulatory approval. Deep expertise in EU and global regulatory frameworks, with a strong track record in defining and executing regulatory strategies for SMEs and innovative programs. Active contributor to the Geneva life sciences ecosystem, serving on the Scientific Committee of the MAS in Drug Discovery and Clinical Development (UNIGE/HUG) and co-leading training on regulatory strategy in product development.

30+ years of experience as a physician‑scientist across academic research, clinical practice and biopharmaceutical development in oncology and immuno‑oncology. Board certified dermatologist, combining deep expertise in molecular biology and immunology with 17+ years in the biopharmaceutical industry. Strong execution track record, having supported 5 companies in advancing compounds into Phase I, 4 of which successfully IPOed or were acquired by large pharmaceutical companies.